The evolving role of alpha-glucosidase inhibitors.
Göke
B
B
Department of Internal Medicine, Philipps University Marburg, Germany.
Herrmann-Rinke
C
C
D020909:Acarbose; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D014312:Trisaccharides / Q000009:adverse effects / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D014312:Trisaccharides; D020909:Acarbose